Should You Buy, Sell, Or Hold Cannabis Stocks Right Now?

By Terry Hacienda, The Fresh Toast on

Published in Cannabis Daily

For 2022 to not be another letdown for cannabis investors and stockholders, lawmakers need to rally around and get the necessary support not only to ensure marijuana remains in the spotlight but to guarantee that legislative changes come to fruition.

Schumer is committed to various reform efforts, and he’s hell-bent on introducing legislation that not only focuses on banking reforms for the industry but also on the bigger picture. In a recent interview, he said that a large percentage of the countries and their lawmakers have discovered that all the myths about cannabis are just that—myths. The drug has more medical and economic benefits to offer Americans. It is not too late or too early to invest.

The Pew Research Center disclosed in a survey report that 91% of U.S. adults support the federal legalization or decriminalization of cannabis for medical or recreational purposes. The probability of this occurring in the Biden Administration is still shaky. Many operators in the industry feel that it is unlikely that such a comprehensive bill like Schumer’s will be passed in the coming months.

Any form of reform would do the trick, though, as investors need assurance. While this is going on, it wouldn’t hurt to look into some of the best cannabis stocks you could invest in right now. What Are Some Of The FANG Stocks Of Weed? Curaleaf Holdings, Inc. (OTC:CURLF)

This company functions as a medical and wellness cannabis center in the United States. There are two arms of operations: cannabis operations and non-cannabis operations. The company recently opened four new dispensaries in Florida and still has plans to open more in the coming months. It also announced that it would be adding more innovative products to its stock.

Planet 13 Holdings Inc. (OTC:PLNHF)

This cannabis company dabbles in all the operations involved in cannabis production and processing. It cultivates, produces, and develops cannabis-derived products for the medical and recreational retail markets in Nevada. The company also distributes and markets these products while operating some of the most significant cannabis dispensaries in California. The company has a lot of value to offer as one of the prominent companies at the forefront of Nevada’s cannabis industry.


Green Thumb Industries

This company manufactures and sells many cannabis products for medical and recreational use in the United States. Last week, the company announced the opening of a new spot in Chelsea, Massachusetts. This brings the number of GreenThumb cannabis stores to 68. The company also disclosed that the store would be rebranded in the new year. Bottom Line Cannabis is here to stay, but only federal reforms can ensure the industry attains the level it ought to reach. National reforms will provide the trading momentum that lasts long enough for investors and shareholders to make significant ROIs. The cannabis sector lacks consistency. Any form of cannabis decriminalization will erase a tremendous amount of doubt and uncertainty in the industry.

This article originally appeared on and has been reposted with permission.

The Fresh Toast is a daily lifestyle platform with a side of cannabis. For more information, visit

The Fresh Toast